NT proBNP

Related by string. * NTS . nt . NTD . nts . nT . Nt . NTs . NTER . nter . nted : NT Rama Rao . SR NTS ISS PRICE . NT BJ Raji . ANNOUNCEME NT . Sequential YoY NT . Nortel Networks NT . NT Vince Wilfork . NTS Realty Holdings . founder NT Rama . minister NT Rama . NT MDT . nigel.tutt @ thomsonreuters.com nt / : proBNP * peptide NT proBNP . NT proBNP assay . NT proBNP Test . RAMP NT proBNP . NT proBNP concentrations *

Related by context. All words. (Click for frequent words.) 69 brain natriuretic peptide 68 cystatin C 65 Lp PLA2 65 D dimer 65 CK MB 65 natriuretic peptide 65 microalbuminuria 64 Troponin T 64 B type natriuretic 64 eGFR 64 glycated hemoglobin HbA1c 64 hsCRP 64 hs CRP 64 procalcitonin 64 troponin T 64 natriuretic peptides 63 tHcy 63 troponins 63 cTnI 63 peptide BNP 63 creatinine levels 63 glomerular filtration rate 63 LVEF 63 NGAL 62 NSTE ACS 62 platelet reactivity 62 HbA1c 62 creatinine 62 nesiritide 62 lactate dehydrogenase LDH 62 thyroglobulin 62 glycated hemoglobin 62 serum creatinine 61 Troponin 61 troponin 61 periprocedural 61 serum creatinine levels 61 antigen PSA 61 LV dysfunction 61 glycated hemoglobin levels 61 glomerular filtration 61 serum PSA 61 hsCRP levels 61 cardiac troponin T 61 serum phosphorus 61 PSADT 60 glycosylated hemoglobin HbA1c 60 echocardiographic parameters 60 serum calcium 60 serum potassium 60 skin sterol 60 galectin 3 60 urine NGAL 60 risk stratification 60 leukocyte count 60 irbesartan 60 plasma renin activity 60 A1c 60 fasting insulin 60 pCR 60 HOMA IR 60 intact parathyroid hormone 60 pg mL 60 pg ml 59 OGTT 59 infarct size 59 PSA nadir 59 hemoglobin A1c HbA1c 59 Lp PLA 2 59 proBNP 59 thyroid stimulating hormone 59 Homocysteine 59 D Dimer 59 eplerenone 59 albumin creatinine ratio 59 HbA 1c 59 biomarker 59 albuminuria 59 C reactive protein 59 glycosylated hemoglobin 59 echocardiographic 59 alanine aminotransferase 59 coronary stenosis 59 levosimendan 59 HbA1C 59 prognostic marker 59 glycemia 59 biochemical recurrence 59 apolipoproteins 58 antigen PSA levels 58 specific antigen PSA 58 Cystatin C 58 tirofiban 58 pioglitazone 58 serum cortisol 58 fasting glucose 58 elevated uric acid 58 serum albumin 58 thyroxine 58 RBP4 58 PCa 58 endoglin 58 univariate analysis 58 QTc prolongation 58 hemoglobin A1c 58 postoperative complication 58 HbA1c levels 58 ATACAND 58 CYP#C# [001] 58 lymphocyte count 58 multivariable analysis 58 elevated creatinine 58 urine albumin 58 AST ALT 58 nonfasting triglyceride levels 58 estimated GFR 58 proteinuria 58 Cardiac Troponin 58 cTnT 58 lipid lowering drugs 58 Prostate Specific Antigen 58 Pioglitazone 58 hemoglobin A1C 58 myocardial perfusion 58 clusterin 58 advanced adenomas 58 inotropic 58 dose atorvastatin 57 ApoB 57 exhaled nitric oxide 57 alanine aminotransferase ALT 57 serum ferritin 57 stable angina 57 serum phosphorous 57 sunitinib 57 Prostate Specific Antigen PSA 57 elevated CRP 57 decompensated heart failure 57 eNO 57 intima media thickness 57 Myoglobin 57 myocardial ischemia 57 eosinophil count 57 albumin protein 57 International Normalized Ratio 57 systolic dysfunction 57 tolvaptan 57 ImmuKnow 57 left ventricular dysfunction 57 platelet function 57 ng mL 57 urinary albumin 57 definite stent thrombosis 57 colorectal adenoma 57 β blockers 57 C Reactive Protein 57 tiotropium 57 fetuin 57 carotid intima media 57 iPTH 57 Hb 57 preoperative PSA 57 serum phosphate 57 mL/min/#.# m 2 57 lactate dehydrogenase 57 candesartan 57 microalbumin 57 peptide NT proBNP 57 mmol L 57 fasting plasma glucose 57 antihypertensive therapy 57 cardiac troponin 57 Score IPSS 57 prostate specific antigen 57 homocysteine 57 XIENCE V PROMUS Stent 57 nondiabetic patients 57 valsartan 57 cardiovascular mortality 57 sensitivity specificity 57 MTWA 57 inflammatory biomarkers 57 #.#ng/ml 57 antithrombotic 57 transferrin saturation 57 Corus CAD 57 hemoglobin Hb 56 warfarin 56 immunohistochemical 56 nonfatal MI 56 renal function 56 FDG PET 56 left ventricular systolic 56 Kaplan Meier analysis 56 renal dysfunction 56 reinfarction 56 diastolic dysfunction 56 macroalbuminuria 56 Prostate specific antigen 56 preserved ejection fraction 56 serum glucose 56 Prognostic 56 lymphocyte counts 56 neoadjuvant chemotherapy 56 urine cytology 56 FDG uptake 56 serum TSH 56 MSMB 56 VKORC1 56 serum testosterone 56 PSA velocity 56 myocardial viability 56 eptifibatide 56 lipoprotein levels 56 metabolic parameters 56 peak VO2 56 beta blocker therapy 56 ng dL 56 invasive coronary angiography 56 CIN2 + 56 aspartate aminotransferase AST 56 KRAS mutation 56 fasting triglycerides 56 binary restenosis 56 creatine kinase 56 mg dL 56 ventricular dysfunction 56 sirolimus eluting stents 56 APTIVUS r 56 subclinical atherosclerosis 56 hematological parameters 56 ST2 56 elevated blood glucose 56 ezetimibe simvastatin 56 myocardial necrosis 56 fosamprenavir 56 distant metastasis 56 bezafibrate 56 glycosylated hemoglobin levels 56 chest radiographs 56 Atacand 56 GSTP1 56 overt nephropathy 56 aspartate aminotransferase 56 Doxil ® 56 pulmonary artery catheterization 56 SCr 56 CsA 56 Echocardiographic 56 plasma creatinine 56 coronary artery disease 56 methylmalonic acid 56 peginterferon alfa 2a 56 prognostic 56 azacitidine 56 serum bilirubin 56 paricalcitol 56 thromboembolism 56 ejection fraction 56 serum triglyceride levels 55 elevated homocysteine 55 aldosterone 55 arterial oxygen saturation 55 sarcosine 55 TPMT 55 plasma glucose 55 stratifying patients 55 serum sodium 55 nondiabetics 55 aminotransferases 55 nonfasting 55 isoprostane 55 Fasting glucose 55 myocardial infarction stroke 55 coronary angiography 55 thyrotropin 55 nicardipine 55 prognostic significance 55 salmeterol fluticasone propionate 55 clopidogrel 55 glulisine 55 postoperative pulmonary 55 insulin glargine 55 Haptoglobin 55 elevated troponin 55 carotid bruit 55 estimated glomerular filtration 55 coronary revascularization 55 nonfatal myocardial infarction 55 PlGF 55 serum triglycerides 55 rs# [002] 55 T2DM 55 anticoagulation 55 S#A# [002] 55 prognostic variables 55 HbA 1C 55 hydroxyvitamin D levels 55 postoperative mortality 55 μmol L 55 subclinical hypothyroidism 55 serum urate levels 55 elevated LDL cholesterol 55 c reactive protein 55 TAXUS Express Stent 55 isolated systolic hypertension 55 hyperkalemia 55 LVSD 55 neutrophil counts 55 lispro 55 lymph node metastasis 55 d dimer 55 systolic hypertension 55 elevated ALT 55 ejection fractions 55 thickness CIMT 55 Cardiotoxicity 55 transaminases 55 sweat chloride 55 osteopontin 55 protein albumin 55 obstructive CAD 55 cardiac dysfunction 55 albumin excretion rate 55 Hemoglobin A1c 55 nonobstructive CAD 55 apolipoprotein B 55 Angiographic 55 Lantus ® 55 idraparinux 55 fasting blood glucose 55 antihypertensive medications 55 pmol L 55 PT INR 55 esomeprazole 55 NYHA functional class 55 SUVmax 55 biomarkers 55 PD2i ® 55 concomitant medications 55 postoperative morbidity 55 abciximab 55 serum uric acid 55 primary aldosteronism 55 cerebrovascular events 55 ng ml 55 Serum creatinine 55 cilostazol 55 fondaparinux 55 TIMP 1 55 upper gastrointestinal bleeding 55 epoetin 55 Microalbuminuria 55 oral antidiabetic medication 55 Hazard Ratio 55 HIV RNA 55 GFR 55 angiography 55 obstructive coronary artery 55 candesartan cilexetil 55 baseline HbA1c 55 SGRQ 55 FOLFOX4 55 hypertensive patients 55 serum estradiol 55 flurpiridaz F 55 VAPRISOL 55 sulphonylureas 55 myeloperoxidase 55 nonfasting triglycerides 55 echocardiography 55 ABCB1 55 MMSE score 55 fluvastatin 55 LV ejection fraction 55 Hcy 55 logistic regression analysis 55 prostate cancer CaP 55 serum IGF 54 urate levels 54 tissue oxygenation 54 radiotherapy RT 54 urinary calcium 54 PSA kinetics 54 HDL C 54 PCA3 54 serum homocysteine 54 hemodilution 54 HE4 54 intravesical therapy 54 VerifyNow 54 HGPIN 54 nmol L 54 TAXUS Stent 54 virologic response 54 urine dipstick 54 carotid IMT 54 EQ 5D 54 TZDs 54 liver metastasis 54 Candesartan 54 systolic 54 HER2 expression 54 5 Fluorouracil 54 triglyceride concentrations 54 protein excretion 54 soluble CD# ligand 54 alkaline phosphatase ALP 54 TMP SMX 54 unfractionated heparin UFH 54 stenoses 54 Cypher Stent 54 platelet aggregation 54 creatinine clearance 54 ALLHAT 54 A1C 54 angiotensin converting enzyme 54 hemoglobin A1c levels 54 lipoprotein 54 chlorthalidone 54 unfractionated heparin 54 angiotensin converting enzyme inhibitors 54 EpCAM expression 54 gefitinib Iressa 54 Hb A1C 54 pharmacokinetic PK profile 54 creatinine ratio 54 Multivariate analysis 54 sirolimus stent 54 pT3 54 anti JCV antibodies 54 serum concentrations 54 serum prostate 54 inflammatory markers 54 aldosterone antagonists 54 hypertensives 54 serum lipid levels 54 glimepiride 54 RE LY trial 54 EGFR TKI 54 immunochemical 54 Logistic regression 54 autoantibodies 54 Nesiritide 54 QTc 54 adiponectin concentrations 54 epoetin alfa 54 prostate cancer PCa 54 dysfunction LVSD 54 quantitative PCR 54 biochemical markers 54 bivariate analysis 54 nonischemic 54 Her2/neu 54 dose clopidogrel 54 renal artery stenosis 54 interobserver reliability 54 SERCA2a 54 undetectable PSA 54 prostate specific 54 tenecteplase 54 carcinoembryonic antigen 54 homocysteine concentrations 54 urinary protein 54 univariate analyzes 54 mammographic density 54 mmHg diastolic 54 lipid abnormalities 54 patients undergoing CABG 54 plasma homocysteine 54 serum thyroglobulin 54 coronary artery calcification 54 carotid stenosis 54 Thrombolysis 54 serum calcium levels 54 resynchronization therapy 54 posttransplant 54 sitosterol 54 HbA 1c levels 54 dose dexamethasone 54 MDRD 54 aspirin clopidogrel 54 revascularization procedures 54 #mmHg [001] 54 hypercholesterolaemia 54 International Prostate Symptom 54 mycophenolate mofetil 54 hyperglycaemia 54 cardiac biomarkers 54 thromboembolic 54 imatinib therapy 54 triiodothyronine 54 sitagliptin 54 NATRECOR R 54 surrogate endpoint 54 adjuvant therapies 54 Creatinine 54 pretest probability 54 serum biomarkers 54 pyridostigmine 54 KRAS mutations 54 HBeAg seroconversion 54 mmol L. 54 HSCT 54 SpO 2 54 IL#B 54 ritonavir boosted 54 arterial stiffness 54 PITX2 methylation 54 #.#mmol L [002] 54 ANOVA 54 Diovan HCT 54 coronary artery calcium 54 plasma triglycerides 54 ischemic cardiomyopathy 54 lymph node metastases 54 antihypertensive agents 54 catheter angiography 54 ACI TIPI 54 chlorambucil 54 F FDG PET 54 Myocardial Infarction 54 ximelagatran 54 induced sputum 54 Ki# 54 liver histology 54 composite endpoint 54 abdominal adiposity 54 platelet inhibition 54 nelfinavir 54 sinus rhythm 54 serum GGT 54 diabetic kidney 54 predictive biomarker 54 triglyceride 54 MACCE 54 IFN beta 54 unstable angina pectoris 54 metabolite concentrations 54 calculated creatinine clearance 54 FDG-PET/CT 54 angiographically 54 left ventricular ejection 54 noninferiority 54 NIHSS score 54 #F FDG PET 54 tumor recurrence 54 antiarrhythmic 54 pressor response 53 univariate 53 SGPT 53 MSCT 53 adiponectin 53 #ng/ml 53 transient elastography 53 intensive statin therapy 53 fructosamine 53 IPSS 53 valvulopathy 53 Thal Dex 53 serum CRP 53 hemodynamic variables 53 MDRD equation 53 ImmuKnow assay 53 DAS# scores 53 olmesartan 53 hematocrit 53 brachial blood 53 allopurinol 53 LMWH 53 stratify patients 53 EBRT 53 prognostic indicator 53 ADAS Cog 53 myocardial infarction MI 53 statistically significant p = 53 symptomatic VTE 53 inotropic agents 53 mitochondrial toxicity 53 STRIDE PD 53 IgG 53 serum urate 53 febuxostat 53 SGOT 53 lumbar spine BMD 53 μg L 53 T2D 53 DAPT 53 secondary hyperparathyroidism 53 BENICAR HCT 53 NMP# 53 serum phosphate levels 53 transaminase levels 53 N telopeptide 53 atrial natriuretic peptide 53 transesophageal echocardiography 53 ACTH 53 OPCAB 53 CTAP# Capsules 53 hemorrhagic complications 53 nonfatal myocardial infarction MI 53 Afib 53 neoadjuvant 53 stress echocardiography 53 cTnT levels 53 calcitriol 53 chemoradiotherapy 53 Enoxaparin 53 PAOD 53 rheumatoid factor 53 sFlt 1 53 esophageal carcinoma 53 inducible ischemia 53 serum cholesterol 53 glucose insulin 53 pancreatic adenocarcinoma 53 thyroid stimulating hormone TSH 53 advanced adenoma 53 myocardial infarction 53 mU liter 53 systolic BP 53 alteplase 53 baseline FEV 53 virologic failure 53 MetS 53 Events MACE 53 mRNA expression 53 serum selenium 53 VT VF 53 impaired renal 53 adenoma recurrence 53 certolizumab 53 left ventricular LV 53 decitabine 53 doxorubicin docetaxel 53 SPECT imaging 53 glargine 53 CTEPH 53 lipid levels 53 pulmonary arterial 53 postmenopausal osteoporotic women 53 benazepril 53 poor metabolizers 53 bioavailable testosterone 53 KRAS mutation status 53 carvedilol 53 FOLPI 53 tipranavir r 53 FEV1 53 Pharmacokinetic 53 genetic polymorphisms 53 Ischemia 53 Oxidized LDL 53 mg dl 53 everolimus eluting stents 53 myocardial uptake 53 dose cytarabine 53 transcranial Doppler ultrasound 53 F2 isoprostanes 53 Wilcoxon rank sum 53 acute coronary syndromes ACS 53 neuroregenerative 53 recurrent ischemia 53 octreotide LAR 53 liver transplant recipients 53 methemoglobin 53 thyrotropin levels 53 atherogenic dyslipidemia 53 left ventricular hypertrophy 53 OptiVol 53 P = .# 53 ptau 53 NMIBC 53 noncardiovascular mortality 53 amlodipine 53 hemodynamic parameters 53 noncardiac 53 ramipril 53 clopidogrel Plavix 53 glycoprotein IIb IIIa inhibitors 53 Clopidogrel 53 left ventricular diastolic 53 contrast echocardiography 53 cytogenic 53 peginterferon 53 Natalizumab 53 undetectable HBV DNA 53 conventional coronary angiography 53 HDL LDL 53 diastolic heart 53 Elitek 53 prognostic biomarker 53 polyp recurrence 53 Hemoglobin 53 Recurrence Score 53 cardiovascular calcification 53 ABC/3TC 53 serum PTH 53 plasma pharmacokinetics 53 tamsulosin 53 antithrombotic therapy 53 achieved statistical significance 53 losartan 53 total cholesterol LDL 53 coinfected patients 53 immunohistochemical staining 53 GFT# 53 standard chemotherapy regimen 53 micrometastasis 53 methylated DNA 53 antithrombotics 53 AEGR 53 ARCOXIA 53 transthoracic 53 pegylated liposomal doxorubicin 53 pharmacodynamic effects 53 cystatin 53 hemodialysis patients 53 antiplatelet therapy 53 ibandronate 53 NIHSS 53 oral anticoagulation 53 dronedarone 53 plasma renin 53 electrocardiography ECG 53 myeloperoxidase MPO 53 intracranial hemorrhage ICH 53 thymosin 53 genotypic resistance 53 thyrotoxicosis 53 clinically meaningful reductions 53 Crohn Disease Activity 53 EXJADE 53 MELD score 53 locoregional disease 53 kidney dysfunction 53 HAAH 53 Albuminuria 53 fasting serum 53 bronchoalveolar lavage 53 Celecoxib 53 BMD measurements 53 PLAC test 53 CYPHER Stent 53 conditional logistic regression 53 cinacalcet 53 perfusion imaging 53 ADHF 53 urate 53 atherothrombotic disease 53 microvascular complications 53 antihypertensive drugs 53 Clusterin 53 immunostaining 52 HBsAg 52 Glomerular filtration rate 52 biochemical relapse 52 plasma fibrinogen 52 angiotensin receptor blockers ARBs 52 renal insufficiency 52 total cholesterol triglycerides 52 acute coronary syndrome 52 urinary albumin excretion 52 tTG 52 endarterectomy 52 cirrhotic patients 52 CC genotype 52 metastatic malignant 52 APTIMA HPV 52 prognostic factor 52 NADiA TM 52 recurrent VTE 52 aldosterone antagonist 52 GRK2 52 BRAF mutation 52 immunochemical fecal occult 52 adiponectin levels 52 pretargeting 52 bendamustine 52 nonsignificant 52 response pCR 52 lipid 52 thromboembolic events 52 ARB telmisartan 52 gadobutrol 52 RE LY ® 52 hemoglobin hematocrit 52 intraobserver 52 dobutamine 52 intracerebral haemorrhage 52 neutrophil count 52 hemodynamics 52 fibrinolytic 52 cytoreductive surgery 52 Fludara 52 diameter stenosis 52 tumor necrosis 52 enoxaparin 52 spiral computed tomography 52 subclinical hyperthyroidism 52 RBP4 levels 52 plasma leptin 52 HERmark 52 serum ALT 52 elevated triglycerides 52 tPSA 52 elevated serum creatinine 52 multivariate Cox 52 B7 H3 52 plasma concentrations 52 haematological 52 elevated LDH 52 mmol l 52 iodixanol 52 BladderChek 52 HIV HCV coinfected 52 serum IgG 52 prognostic markers 52 anti Xa 52 antihypertensives 52 ivabradine 52 PITX2 52 fatal myocardial infarction 52 lymphadenectomy 52 dalteparin 52 Myelodysplastic Syndrome MDS 52 thrombotic thrombocytopenic purpura TTP 52 florbetaben 52 ferritin 52 haematologic 52 cardiovascular hospitalization 52 fluorouracil 52 ventricular dyssynchrony 52 IGFBP 52 etanercept 52 posaconazole 52 strontium ranelate 52 Framingham Risk Score 52 graft occlusion 52 preoperative 52 Ramipril 52 malondialdehyde 52 lupus anticoagulant 52 Subgroup analysis 52 glucose concentrations 52 Acute Coronary Syndromes 52 distant metastases 52 BEXXAR Therapeutic Regimen 52 metformin 52 triglyceride TG 52 invasive angiography 52 intracoronary 52 Heart Failure Patients 52 leflunomide 52 liposomal amphotericin B 52 simvastatin ezetimibe 52 euthyroid 52 atypia 52 endogenous EPO 52 hepatorenal syndrome 52 cangrelor 52 tumor histology 52 hydroxy vitamin D 52 = #.#-#.# 52 antidiabetic medication 52 bone resorption 52 exhaled NO 52 dyssynchrony 52 valvular disease 52 antidiabetic drugs 52 thyroid nodules 52 plasma lipid 52 hepatic function 52 tacrolimus 52 Montgomery Åsberg Depression 52 #F FDG 52 UKPDS 52 Apidra ® 52 PD2i R 52 multivariate analyzes 52 Quantitation 52 SSc 52 pretransplant 52 erythrocyte sedimentation rate 52 IFN α 52 Subgroup analyzes 52 trastuzumab 52 T#I [002] 52 muraglitazar 52 SNP rs# [001] 52 TACE 52 variceal hemorrhage 52 Secondary efficacy endpoints 52 A1c levels 52 Vidaza azacitidine 52 anticoagulation therapy 52 thrombotic events 52 A2 Lp PLA2 52 serum vitamin D 52 microsatellite instability 52 intraocular pressure IOP 52 beta blocker 52 GP IIb IIIa inhibitor 52 clinically localized prostate 52 abacavir Ziagen 52 tamponade 52 Septin9 52 atorvastatin #mg 52 TAXUS stent 52 baseline serum creatinine 52 ^ sup #m 52 intravascular ultrasonography 52 Prognostic Value 52 dutasteride 52 C telopeptide 52 preoperatively 52 interferon ribavirin 52 confidence interval #.#-#.# 52 ACE inhibitor 52 p tau 52 spironolactone 52 isoproterenol 52 sCJD 52 Unified Parkinson Disease 52 interobserver agreement 52 mIU L 52 ventricular remodeling 52 pulmonary capillary wedge 52 oral glucose tolerance 52 antibody titer 52 alkaline phosphatase 52 bypass graft CABG surgery 52 Stent thrombosis 52 QT QTc 52 isoenzyme 52 HES CEL 52 LQTS 52 P#Y# [002] 52 insulin detemir 52 serum biomarker 52 vertebral fracture 52 sustained virological response 52 Losartan 52 tocilizumab 52 A1C levels 52 colesevelam 52 ULORIC 52 fasting plasma 52 reintervention 52 statin 52 electron beam computed tomography 52 perindopril 52 preoperative chemotherapy 52 thrombolytic agents 52 BYSTOLIC 52 warfarin therapy 52 angiotensin receptor blocker ARB 52 hip BMD 52 residual platelet reactivity 52 white matter hyperintensities 52 HER2 overexpression 52 statistically significant p 52 tipranavir 52 EGFR mutation status 52 nitrotyrosine 52 paclitaxel eluting stents 52 APOC3 52 x ULN 52 QTcF 52 scintigraphic 52 Logistic regression analysis 52 endometrial thickness 52 severe hypoglycemia 52 K ras mutations 52 DEFINITY ® 52 ABL1 52 TNFalpha 52 cardiovascular hospitalizations 52 p = #.# [003] 52 oncologic outcomes 52 Ambulatory Blood Pressure 52 plasma folate 52 verapamil 52 unpaired t 52 anemia hemoglobin 52 lipid lowering therapy 52 dose melphalan 52 immunosuppressive regimen 52 Immunohistochemistry 52 multivariate logistic regression 52 abnormal glucose metabolism 52 FENO 52 calcium channel 52 Percutaneous Coronary Intervention 52 urinary excretion 52 repeat revascularization 52 rs# [004] 52 locoregional 52 mITT population

Back to home page